Recent Finacing
Recent Raise
Stipe Therapeutics develops modulators of intracellular STING protein–protein interactions to sensitize innate immunity, demonstrating preclinical antitumor activity and tumor-microenvironment modulation for hematologic and solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
